======= S100B ======= == Gene Information == * **Official Symbol**: S100B * **Official Name**: S100 calcium binding protein B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6285|6285]] * **UniProt**: [[https://www.uniprot.org/uniprot/P04271|P04271]] * **Interactions**: [[https://thebiogrid.org/search.php?search=S100B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20S100B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/176990|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Weakly binds calcium but binds zinc very tightly- distinct binding sites with different affinities exist for both ions on each monomer. Physiological concentrations of potassium ion antagonize the binding of both divalent cations, especially affecting high-affinity calcium-binding sites. Binds to and initiates the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization. May mediate calcium-dependent regulation on many physiological processes by interacting with other proteins, such as TPR-containing proteins, and modulating their activity. {ECO:0000269|PubMed:20351179, ECO:0000269|PubMed:22399290}. |S 100| |efhand| |negative regulation of skeletal muscle cell differentiation| |response to methylmercury| |RAGE receptor binding| |negative regulation of skeletal muscle tissue development| |S100 protein binding| |positive regulation of myelination| |regulation of skeletal muscle cell differentiation| |regulation of myelination| |tau protein binding| |long-term synaptic potentiation| |negative regulation of striated muscle tissue development| |negative regulation of muscle organ development| |regulation of skeletal muscle tissue development| |negative regulation of muscle tissue development| |astrocyte differentiation| |regulation of neuronal synaptic plasticity| |calcium-dependent protein binding| |positive regulation of nervous system process| |ruffle| |memory| |regulation of striated muscle tissue development| |regulation of muscle tissue development| |regulation of muscle organ development| |regulation of nervous system process| |response to glucocorticoid| |positive regulation of synaptic transmission| |regulation of cell shape| |response to corticosteroid| |glial cell differentiation| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |cellular response to hypoxia| |regulation of synaptic plasticity| |cellular response to decreased oxygen levels| |gliogenesis| |cellular response to oxygen levels| |regulation of I-kappaB kinase/NF-kappaB signaling| |learning or memory| |cognition| |response to steroid hormone| |response to hypoxia| |response to decreased oxygen levels| |axonogenesis| |neuronal cell body| |response to oxygen levels| |axon development| |cell morphogenesis involved in neuron differentiation| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |regulation of cell morphogenesis| |cell part morphogenesis| |positive regulation of nervous system development| |cell morphogenesis involved in differentiation| |behavior| |regulation of system process| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |neuron projection development| |perinuclear region of cytoplasm| |positive regulation of cell death| |negative regulation of cell differentiation| |calcium ion binding| |cell morphogenesis| |innate immune response| |neuron development| |cellular component morphogenesis| |zinc ion binding| |response to lipid| |protein homodimerization activity| |response to hormone| |positive regulation of cell population proliferation| |response to organic cyclic compound| |regulation of nervous system development| |negative regulation of developmental process| |defense response to other organism| |central nervous system development| |neuron differentiation| |positive regulation of intracellular signal transduction| |regulation of anatomical structure morphogenesis| |identical protein binding| |plasma membrane bounded cell projection organization| |response to abiotic stimulus| |cell projection organization| |negative regulation of multicellular organismal process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |positive regulation of developmental process| |nervous system process| |response to endogenous stimulus| |generation of neurons| |regulation of apoptotic process| |regulation of programmed cell death| |extracellular space| |regulation of cell population proliferation| |neurogenesis| |cell development| |positive regulation of signal transduction| |regulation of cell death| |cellular response to stress| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |immune response| |extracellular region| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-1.83| |[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|-1.71| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5441 * **Expression level (log2 read counts)**: -1.03 {{:chemogenomics:nalm6 dist.png?nolink |}}